Submitted by Anonymous (not verified) on 12 March 2026 - 16:20
Human medicines European public assessment report (EPAR): Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto), lenalidomide, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised
Source:
